Literature DB >> 24581903

Systematic review of the prognosis after mild traumatic brain injury in adults: cognitive, psychiatric, and mortality outcomes: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis.

Linda J Carroll1, J David Cassidy2, Carol Cancelliere3, Pierre Côté4, Cesar A Hincapié5, Vicki L Kristman6, Lena W Holm7, Jörgen Borg8, Catharina Nygren-de Boussard8, Jan Hartvigsen9.   

Abstract

OBJECTIVE: To synthesize the best available evidence on objective outcomes after adult mild traumatic brain injury (MTBI). DATA SOURCES: MEDLINE and other databases were searched (2001-2012) for studies related to MTBI. Inclusion criteria included published, peer-reviewed articles in English and other languages. References were also identified from the bibliographies of eligible articles. STUDY SELECTION: Randomized controlled trials and cohort and case-control studies were selected according to predefined criteria. Studies had to have a minimum of 30 MTBI cases and assess objective outcomes in adults. DATA EXTRACTION: Eligible studies were critically appraised using a modification of the Scottish Intercollegiate Guidelines Network (SIGN) criteria. Two reviewers independently reviewed each study and extracted data from accepted articles into evidence tables. DATA SYNTHESIS: Evidence was synthesized qualitatively according to modified SIGN criteria, and studies were categorized as exploratory or confirmatory based on the strength of their design and evidence. After 77,914 records were screened, 299 were found to be relevant and critically reviewed, and 101 were deemed scientifically admissible. Of these, 21 studies that were related to the objective outcomes form the basis of this review. Most evidence indicates the presence of cognitive deficits in the first 2 weeks post-MTBI, and some evidence suggests that complete recovery may take 6 months or a year. A small number of studies indicate that MTBI increases the risk of psychiatric illnesses and suicide.
CONCLUSIONS: Early cognitive deficits are common, and complete recovery may be prolonged. Conclusions about mortality post-MTBI are limited. This review has implications for expected recovery after MTBI and MTBI-related health sequelae. Well-designed confirmatory studies are needed to understand the medium- to long-term consequences of MTBI and to further evaluate the effect of prior MTBI and injury severity on recovery.
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniocerebral trauma; Mortality; Recovery of function; Rehabilitation

Mesh:

Year:  2014        PMID: 24581903     DOI: 10.1016/j.apmr.2013.08.300

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  62 in total

1.  Early Changes in Cortical Emotion Processing Circuits after Mild Traumatic Brain Injury from Motor Vehicle Collision.

Authors:  Xin Wang; Hong Xie; Andrew S Cotton; Kristopher R Brickman; Terrence J Lewis; John T Wall; Marijo B Tamburrino; William R Bauer; Kenny Law; Samuel A McLean; Israel Liberzon
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

Review 2.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

3.  Plasma Tau and Amyloid Are Not Reliably Related to Injury Characteristics, Neuropsychological Performance, or White Matter Integrity in Service Members with a History of Traumatic Brain Injury.

Authors:  Sara M Lippa; Ping-Hong Yeh; Jessica Gill; Louis M French; Tracey A Brickell; Rael T Lange
Journal:  J Neurotrauma       Date:  2019-04-09       Impact factor: 5.269

4.  COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment.

Authors:  John M Myrga; Shannon B Juengst; Michelle D Failla; Yvette P Conley; Patricia M Arenth; Anthony A Grace; Amy K Wagner
Journal:  Neurorehabil Neural Repair       Date:  2016-05-06       Impact factor: 3.919

5.  Neurobehavioral Characteristics of Older Veterans With Remote Traumatic Brain Injury.

Authors:  Carrie B Peltz; Raquel C Gardner; Kimbra Kenney; Ramon Diaz-Arrastia; Joel H Kramer; Kristine Yaffe
Journal:  J Head Trauma Rehabil       Date:  2017 Jan/Feb       Impact factor: 2.710

6.  Epidemiology of Isolated Versus Nonisolated Mild Traumatic Brain Injury Treated in Emergency Departments in the United States, 2006-2012: Sociodemographic Characteristics.

Authors:  Carol Cancelliere; Victor G Coronado; Christopher A Taylor; Likang Xu
Journal:  J Head Trauma Rehabil       Date:  2017 Jul/Aug       Impact factor: 2.710

7.  Diagnostic Algorithms to Study Post-Concussion Syndrome Using Electronic Health Records: Validating a Method to Capture an Important Patient Population.

Authors:  Jessica Dennis; Aaron M Yengo-Kahn; Paul Kirby; Gary S Solomon; Nancy J Cox; Scott L Zuckerman
Journal:  J Neurotrauma       Date:  2019-03-28       Impact factor: 5.269

8.  Cerebral perfusion disturbances in chronic mild traumatic brain injury correlate with psychoemotional outcomes.

Authors:  Efrosini Papadaki; Eleftherios Kavroulakis; Katina Manolitsi; Dimitrios Makrakis; Emmanouil Papastefanakis; Pelagia Tsagaraki; Styliani Papadopoulou; Alexandros Zampetakis; Margarita Malliou; Antonios Vakis; Panagiotis Simos
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

9.  Discordance between Documented Criteria and Documented Diagnosis of Traumatic Brain Injury in the Emergency Department.

Authors:  Martin R Cota; Anita D Moses; Neekita R Jikaria; Katie C Bittner; Ramon R Diaz-Arrastia; Lawrence L Latour; L Christine Turtzo
Journal:  J Neurotrauma       Date:  2018-12-04       Impact factor: 5.269

10.  MR Imaging Applications in Mild Traumatic Brain Injury: An Imaging Update.

Authors:  Xin Wu; Ivan I Kirov; Oded Gonen; Yulin Ge; Robert I Grossman; Yvonne W Lui
Journal:  Radiology       Date:  2016-06       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.